Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Lyric Health has announced a partnership with Scala.AI to enhance its healthcare engagement and care navigation platform using AI. The collaboration will focus on improving member engagement, care coordination, and operational efficiency across virtual care services.
Boston Consulting Group announced a $500 million commitment by 2030 to advance AI for social impact, partnering with Anthropic to support non-profits and philanthropies in areas such as education, health care, and poverty reduction.
Compal Electronics unveiled a biotechnology platform that combines quantum computing and artificial intelligence at COMPUTEX 2026, highlighting collaborations with universities and pharmaceutical firms for drug discovery and manufacturing.
Qaelon Medical and Scialytics have formed a partnership to integrate Qaelon's physiologic gastrointestinal data into Scialytics' AI surgical analytics platform, aiming to improve risk detection and surgical outcomes in colorectal procedures.
OSF HealthCare has expanded its partnership with hellocare.ai to deploy the company's Intelligent Hospital Room platform across all inpatient facilities, integrating virtual nursing, patient safety, and engagement tools into a unified system.
VIDIZMO has introduced the AI Intelligence Hub, a platform that analyzes video, audio, documents, and images together on private or air-gapped infrastructure. The system is designed for sectors such as law enforcement, healthcare, and financial services to deliver sourced and auditable answers.
CorrectSequence Therapeutics announced 15-month follow-up results showing that its CS-206 base editing therapy maintained lasting efficacy and a favorable safety profile in a patient with sickle cell disease, with no vaso-occlusive crises or anemia observed.
First Foundation Labs, a life sciences AI company spun out of Luma Group, announced a collaboration with Microsoft to integrate its clinical and translational reasoning platform into Microsoft Discovery, enhancing AI capabilities for drug development and research.
Ingenix has raised €13 million in seed extension funding led by Sofinnova Partners to scale its Biological Reasoning Engine and launch the Qualified Access Program for pharma and biotech partners.
Adaptive Innovations has raised $50 million in Series A funding led by Felicis, with participation from Bain Capital Ventures and others. The funding will support the expansion of its AI healthcare platform and clinical workforce across new states.
The American Diabetes Association’s Innovation Fund has made a strategic investment in UpDoc to advance its clinical AI platform for chronic disease management and prevention.
WeInfuse has announced a partnership with Trial IQ Technologies to integrate AI tools that help infusion providers launch and manage clinical trial programs, expanding access to research within community care settings.
Mayo Clinic and Microsoft have announced a collaboration to build a frontier AI model designed specifically for healthcare, combining Mayo's clinical expertise with Microsoft's AI and cloud capabilities.
Pathwork has introduced an AI platform that gives life insurance brokers instant access to prescription and medical claims data, allowing faster and more informed underwriting decisions.
Acclinate and HCN Global have announced a partnership integrating their health engagement networks to improve clinical trial participation among Hispanic and Latino populations, using Acclinate's e-DICT platform and predictive analytics tools.
RSC Bay Area has become the first fertility clinic in the United States to use Alife Health’s FDA-cleared Embryo Predict AI tool in routine IVF care, providing patients with AI-assisted embryo selection.
Mount Sinai Health System will implement Clarium’s AI-powered computer vision technology across its hospitals to automate surgical supply tracking and reduce waste, according to a press release.
Converge Bio has secured a $2.5 million grant from the Gates Foundation to expand its AI gene discovery platform from pharmaceuticals to crop genomics, aiming to improve agricultural resilience and accelerate crop breeding cycles.
Tissue Dynamics and Galmed Pharmaceuticals have discovered a previously unknown metabolic mechanism involved in cardiac fibrosis using human cardiac organoid models, showing that a combination of Aramchol Meglumine and a PPARα agonist can significantly reduce fibrotic burden.
The U.S. Food and Drug Administration has cleared Clarius Mobile Health's Ejection Fraction AI tool, which automates cardiac ultrasound analysis to measure heart pumping efficiency in real time within the Clarius App.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
